Tokyo Metropolitan Komagome Hospital

Bunkyō City 1138677

6 studies enrolling now · 7 studies all time

What they study most

Acute-graft-versus-host Disease, Carcinoma, Non-Small-Cell Lung, Extensive-stage Small-cell Lung Cancer, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Metabolic Dysfunction-Associated Steatotic Liver Disease, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasm Metastasis, Non-small Cell Lung Cancer

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant — Completed